Studies on how combinations of drugs (like TKIs and anti-CTLA-4) treat sarcoma, particularly Alveolar Soft Part Sarcoma.
This research, likely part of the dataset, analyzed tumor sequencing to identify the amplification of genes such as MDM2 and CDK4 in 12q14-15. It connects these molecular findings to survival and metastasis rates in patients, noting that MDM2 amplification is a key marker distinguishing DDLPS from benign tumors. 13569.rar
If you can specify whether you are looking for or genetic sequencing data from this file, I can provide more precise information. Studies on how combinations of drugs (like TKIs
Immune checkpoint inhibitors in sarcomas: a systematic review If you can specify whether you are looking
Genomic alterations and clinical outcomes in patients with dedifferentiated liposarcoma
The provided search results do not contain an article named "13569.rar" directly. However, they indicate this number is likely part of an identifier for research regarding , specifically Dedifferentiated Liposarcoma (DDLPS) , a common form of soft tissue tumor.
Other related research topics often found in similar databases include: